Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

NCT02603146 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

144

Enrollment

NIH

Sponsor class

Stopped Enrollment was closed before reaching the target. In the 1st interim analysis after enrollment closure, the follow up \& treatment of active participants were stopped early due to evidence of futility.

Conditions

Healthy Participants
Rheumatoid Arthritis (RA) Prevention

Interventions

DRUG: Hydroxychloroquine
DRUG: HCQ Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]